
Mubadala Capital Ventures
Description
Mubadala Capital Ventures is the dedicated venture capital arm of Mubadala Investment Company, a prominent sovereign investor based in Abu Dhabi. Operating globally with a significant presence in San Francisco, the firm strategically invests in disruptive technologies across various stages. Its mandate is to back innovative companies poised for significant growth, leveraging the extensive network and resources of its parent company. Mubadala Capital Ventures focuses on sectors such as artificial intelligence, enterprise software, fintech, health tech, and consumer internet, seeking out founders who are building the next generation of industry leaders.
The firm employs a multi-stage investment strategy, deploying capital through distinct funds tailored to different growth phases. For early-stage opportunities, Mubadala Capital Ventures has raised dedicated vehicles, including the $400 million Mubadala Ventures I fund launched in 2017, and subsequent funds. These early-stage investments typically target companies from Series A onwards, providing crucial capital and strategic guidance to help them scale. The firm is known for its long-term partnership approach, offering portfolio companies access to global markets and strategic relationships within Mubadala's vast ecosystem.
In addition to early-stage investments, Mubadala Capital Ventures has a robust growth equity practice. This is exemplified by the launch of its $750 million Mubadala Ventures IV fund in 2022, specifically designed to support more mature, high-growth companies. This growth fund allows the firm to make substantial follow-on investments in its successful portfolio companies or lead significant rounds for new, later-stage opportunities. Through its comprehensive investment approach, Mubadala Capital Ventures aims to be a value-add investor, providing not just capital but also operational expertise and global market access to accelerate the success of its portfolio.
Investor Profile
Mubadala Capital Ventures has backed more than 121 startups, with 1 new investments in the last 12 months alone. The firm has led 29 rounds, about 24% of its total and boasts 23 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, Germany, United Kingdom.
- Strong thematic focus on Health Care, Biotechnology, Software.
- Typical check size: $1M – $75M.
Stage Focus
- Series A (26%)
- Series B (23%)
- Series C (12%)
- Series D (8%)
- Seed (8%)
- Post Ipo Equity (7%)
- Series Unknown (7%)
- Series E (5%)
- Private Equity (3%)
- Series F (1%)
Country Focus
- United States (72%)
- Germany (6%)
- United Kingdom (5%)
- China (3%)
- Sweden (2%)
- Austria (2%)
- France (2%)
- United Arab Emirates (2%)
- Russian Federation (2%)
- Switzerland (1%)
Industry Focus
- Health Care
- Biotechnology
- Software
- Therapeutics
- Artificial Intelligence (Ai)
- Information Technology
- Medical
- Life Science
- Pharmaceutical
- Financial Services
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.